Physician profile
Michael Robertson
NPI 1184655409
$3,557.43
in general payments reported to CMS, 2019-2025
20 companies · $332 in 2025
The $332 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $656 · 2020: $1,634 · 2021: $136 · 2022: $319 · 2023: $113 · 2024: $368 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $813.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,444.34 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Watchman Access System |
| Biosense Webster, INC. | $127.89 | 2024 | Nuvision Ice Catheter |
| Genentech USA, INC. | $125.00 | 2019 | |
| Stryker Corporation | $119.04 | 2025 | Flowtriever, Artix Mt |
| Livanova USA, INC. | $105.50 | 2020 | |
| Abiomed | $99.63 | 2024 | |
| Novartis Pharmaceuticals Corporation | $73.87 | 2019-2025 | |
| Cardiovascular Systems INC. | $71.42 | 2019-2020 | |
| Ge Healthcare | $66.88 | 2025 | |
| Abbott Laboratories | $61.60 | 2023-2024 | Diamondback Coronary, Amplatzer Amulet |
| Philips North America LLC | $55.27 | 2020-2021 | |
| Allergan, INC. | $31.62 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $30.64 | 2020 | |
| Pfizer INC. | $29.17 | 2024-2025 | |
| Shockwave Medical, INC | $27.54 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $22.74 | 2020 | |
| Amgen INC. | $20.74 | 2022 | |
| Altathera Pharmaceuticals LLC | $17.70 | 2022 | |
| Biotronik INC. | $13.42 | 2024 | Nhancer Rx, Recross |
| Sanofi-Aventis U.S. LLC | $13.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.